Pacific Point Advisors LLC Acquires Shares of 14,836 Colgate-Palmolive (NYSE:CL)

Pacific Point Advisors LLC purchased a new position in Colgate-Palmolive (NYSE:CL - Free Report) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm purchased 14,836 shares of the company's stock, valued at approximately $1,283,000.

A number of other institutional investors also recently bought and sold shares of the stock. Barclays PLC raised its holdings in Colgate-Palmolive by 38.7% during the third quarter. Barclays PLC now owns 7,644,189 shares of the company's stock valued at $793,542,000 after acquiring an additional 2,132,747 shares during the period. Ameritas Advisory Services LLC grew its stake in shares of Colgate-Palmolive by 18.0% in the 4th quarter. Ameritas Advisory Services LLC now owns 2,604 shares of the company's stock worth $237,000 after buying an additional 398 shares in the last quarter. MassMutual Private Wealth & Trust FSB increased its position in shares of Colgate-Palmolive by 3.3% during the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 4,187 shares of the company's stock valued at $381,000 after purchasing an additional 133 shares during the last quarter. Koshinski Asset Management Inc. lifted its position in Colgate-Palmolive by 7.2% in the fourth quarter. Koshinski Asset Management Inc. now owns 8,292 shares of the company's stock worth $754,000 after buying an additional 558 shares during the last quarter. Finally, Atomi Financial Group Inc. increased its position in Colgate-Palmolive by 6.5% during the fourth quarter. Atomi Financial Group Inc. now owns 6,489 shares of the company's stock valued at $590,000 after acquiring an additional 394 shares during the last quarter. 80.41% of the stock is owned by institutional investors.

Colgate-Palmolive Stock Performance

NYSE:CL traded up $1.77 during mid-day trading on Monday, hitting $92.67. The company's stock had a trading volume of 6,723,726 shares, compared to its average volume of 4,677,772. The business's fifty day moving average is $91.81 and its two-hundred day moving average is $91.25. The stock has a market cap of $75.10 billion, a price-to-earnings ratio of 26.33, a PEG ratio of 4.20 and a beta of 0.39. The company has a debt-to-equity ratio of 13.40, a current ratio of 0.92 and a quick ratio of 0.58. Colgate-Palmolive has a 1 year low of $85.32 and a 1 year high of $109.30.

Colgate-Palmolive (NYSE:CL - Get Free Report) last issued its quarterly earnings data on Friday, April 25th. The company reported $0.91 EPS for the quarter, topping analysts' consensus estimates of $0.86 by $0.05. Colgate-Palmolive had a net margin of 14.38% and a return on equity of 477.77%. The business had revenue of $4.91 billion for the quarter, compared to analysts' expectations of $4.92 billion. During the same quarter last year, the company earned $0.86 EPS. The business's revenue was down 3.0% on a year-over-year basis. Analysts anticipate that Colgate-Palmolive will post 3.75 EPS for the current fiscal year.

Colgate-Palmolive Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Thursday, May 15th. Shareholders of record on Thursday, April 17th were given a $0.52 dividend. The ex-dividend date was Thursday, April 17th. This represents a $2.08 dividend on an annualized basis and a dividend yield of 2.24%. This is an increase from Colgate-Palmolive's previous quarterly dividend of $0.50. Colgate-Palmolive's dividend payout ratio is 58.76%.

Colgate-Palmolive declared that its board has authorized a share buyback program on Thursday, March 20th that authorizes the company to buyback $5.00 billion in shares. This buyback authorization authorizes the company to purchase up to 6.8% of its stock through open market purchases. Stock buyback programs are typically a sign that the company's board believes its stock is undervalued.

Wall Street Analyst Weigh In

CL has been the topic of several recent analyst reports. Stifel Nicolaus reduced their price target on Colgate-Palmolive from $95.00 to $93.00 and set a "hold" rating on the stock in a report on Monday, February 3rd. Wells Fargo & Company increased their target price on shares of Colgate-Palmolive from $83.00 to $88.00 and gave the stock an "underweight" rating in a report on Wednesday, April 2nd. JPMorgan Chase & Co. upped their target price on Colgate-Palmolive from $95.00 to $103.00 and gave the stock an "overweight" rating in a report on Monday, April 28th. Raymond James restated an "outperform" rating and issued a $105.00 price target (down from $110.00) on shares of Colgate-Palmolive in a report on Monday, February 3rd. Finally, Royal Bank of Canada reissued a "sector perform" rating and issued a $101.00 price objective on shares of Colgate-Palmolive in a research report on Wednesday, January 29th. One equities research analyst has rated the stock with a sell rating, ten have issued a hold rating and ten have issued a buy rating to the company. According to MarketBeat.com, Colgate-Palmolive currently has a consensus rating of "Hold" and a consensus target price of $102.12.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.